Methylation-driven gene DLL3 is a potential prognostic biomarker in ocular melanoma correlating with metastasis
BackgroundOcular melanoma is an aggressive malignancy with a high rate of metastasis and poor prognosis. Increasing evidence indicated that DNA methylation plays an important role in the occurrence and development of ocular melanoma. Hence, exploring new diagnostic and prognostic biomarkers at the g...
Main Authors: | Ludi Yang, Gaoming Wang, Hanhan Shi, Shichong Jia, Jing Ruan, Ran Cui, Shengfang Ge |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-10-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.964902/full |
Similar Items
-
Publication trends of research on conjunctival melanoma during 1997–2022: A 25-year bibliometric study
by: Wei Xu, et al.
Published: (2022-08-01) -
Distinct expression patterns of Notch ligands, Dll1 and Dll4, in normal and inflamed mice intestine
by: Hiromichi Shimizu, et al.
Published: (2014-05-01) -
Development and application of OPC server based on ASOPCDA.DLL dynamic link library
by: JING Jing
Published: (2015-05-01) -
Novel small molecule DMAMCL induces differentiation in rhabdomyosarcoma by downregulating of DLL1
by: Qi Li, et al.
Published: (2024-05-01) -
Epigenetic drug library screening reveals targeting DOT1L abrogates NAD+ synthesis by reprogramming H3K79 methylation in uveal melanoma
by: Xiang Gu, et al.
Published: (2023-01-01)